Search research articles
Contact Us
Filters
Showing results (121-130 of 129) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 129 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2000
Factors predicting for efficacy and safety of docetaxel in a compassionate-use cohort of 825 heavily pretreated advanced breast cancer patients
J Alexandre, P Bleuzen, J Bonneterre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 13, 2000
Oxaliplatin added to 5-fluorouracil-based therapy (5-FU +/- FA) in the treatment of 5-FU-pretreated patients with advanced colorectal carcinoma (ACRC): results from the European compassionate-use program
S Brienza, M A Bensmaïne, P Soulié, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1996
Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil
P Wibault, M A Bensmaine, M de Forni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 28, 2002
Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients
C Louvet, T André, J M Tigaud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2004
Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patients
M Ducreux, E Mitry, M Ould-Kaci, et al.
Anti-Cancer Drugs
|
October 18, 2001
Search for metabolites of ecteinascidin 743, a novel, marine-derived, anti-cancer agent, in man
R W Sparidans, H Rosing, M J Hillebrand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Phase III trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer. Head and Neck Interferon Cooperative Study Group
D Schrijvers, J Johnson, U Jiminez, et al.
Cancer Chemotherapy and Pharmacology
|
January 22, 2002
A comparison of limited sampling strategies for prediction of Ecteinascidin 743 clearance when administered as a 24-h infusion
C van Kesteren, R A Mathĵt, L López-Lázaro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2001
Pharmacokinetics and pharmacodynamics of the novel marine-derived anticancer agent ecteinascidin 743 in a phase I dose-finding study
C van Kesteren, E Cvitkovic, A Taamma, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 129) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 129 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2000
Factors predicting for efficacy and safety of docetaxel in a compassionate-use cohort of 825 heavily pretreated advanced breast cancer patients
J Alexandre, P Bleuzen, J Bonneterre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 13, 2000
Oxaliplatin added to 5-fluorouracil-based therapy (5-FU +/- FA) in the treatment of 5-FU-pretreated patients with advanced colorectal carcinoma (ACRC): results from the European compassionate-use program
S Brienza, M A Bensmaïne, P Soulié, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1996
Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil
P Wibault, M A Bensmaine, M de Forni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 28, 2002
Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients
C Louvet, T André, J M Tigaud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2004
Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patients
M Ducreux, E Mitry, M Ould-Kaci, et al.
Anti-Cancer Drugs
|
October 18, 2001
Search for metabolites of ecteinascidin 743, a novel, marine-derived, anti-cancer agent, in man
R W Sparidans, H Rosing, M J Hillebrand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Phase III trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer. Head and Neck Interferon Cooperative Study Group
D Schrijvers, J Johnson, U Jiminez, et al.
Cancer Chemotherapy and Pharmacology
|
January 22, 2002
A comparison of limited sampling strategies for prediction of Ecteinascidin 743 clearance when administered as a 24-h infusion
C van Kesteren, R A Mathĵt, L López-Lázaro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2001
Pharmacokinetics and pharmacodynamics of the novel marine-derived anticancer agent ecteinascidin 743 in a phase I dose-finding study
C van Kesteren, E Cvitkovic, A Taamma, et al.
Page
of 13